Critical timing for these discussions includes the initial prescribing visit, any dose escalation appointments, and whenever new medications are added to the treatment regimen
Currently, insulin therapy for persons with type 2 diabetes is traditionally added to an anti-hyperglycemic regimen Read More The Efficacy of Saxagliptin in Combination Therapy Dec 5, 2014 Articles, DPP-4 Therapy Center, Sulfonylurea 8,953 views Saxagliptin shows improved glycemic control when added to other classes of medications in type 2 diabetes patients Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by extending the half-life of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
Turmeric can help boost your metabolism
ATF4 protects the heart from failure by antagonizing oxidative stress
26, 2024: This article was updated to include a proposal for Medicare and Medicaid to cover obesity drugs
For Media Inquiries and AHA Expert Perspective: AHA Communications & Media Relations in Dallas: 214-706-1173
